Duloxetine, a potent SNRI, reduced neuropathic pain in an animal model and significantly improved painful physical symptoms associated with depression in a study of patients with major depressive disorder [44,45]
BPC-157 Protocol (2 mL Reconstitution = 2.5 mg/mL) Route: Subcutaneous injection, preferably near the site of injury
Interactions With other peptides Complementary but use different timingPEG-MGF post-workout activates satellite cells, IGF-1 LR3 on rest days supports protein synthesis
According to the company, MadeMed Club members ($149 per year) receive a $10 per month discount
Patient Consent Statement Patient consent was not required for this manuscript as FAERS data is freely accessible via the FDA website
BPC-157 is a synthetic peptide that has attracted research interest in areas related to tissue biology, angiogenesis, and cellular repair mechanisms